share_log

北京海润天睿律师事务所关于荣昌生物制药(烟台)股份有限公司2022年A股限制性股票激励计划之A类权益第一个归属期符合归属条件及作废部分已授予尚未归属的限制性股票的法律意见书

Legal Opinion of Beijing Hairun Tianrui Law Firm on Rongchang Biopharmaceutical (Yantai) Co., Ltd.\'s 2022 A-share Restricted Stock Incentive Plan that met the conditions of ownership during the first vesting period and that the annulled portion was grante

Sensex a share ·  Dec 29, 2023 11:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more